| Name | methyl 2-(2-amino-5-methyl-1,3-thiazol-4-yl)acetate |
|---|---|
| Synonyms |
4-Thiazoleacetic acid, 2-amino-5-methyl-, methyl ester
(2-amino-5-methyl-thiazol-4-yl)-acetic acid methyl ester Methyl (2-amino-5-methyl-1,3-thiazol-4-yl)acetate methylaminomethylthiazolylacetate methyl 2-(2-amino-5-methyl-thiazol-4-yl)acetate |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 324.2±27.0 °C at 760 mmHg |
| Molecular Formula | C7H10N2O2S |
| Molecular Weight | 186.232 |
| Flash Point | 149.9±23.7 °C |
| Exact Mass | 186.046295 |
| PSA | 94.18000 |
| LogP | 0.59 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.580 |
| HS Code | 2934100090 |
|---|
|
~64%
259654-73-4 |
| Literature: BAYER PHARMACEUTICALS CORPORATION Patent: WO2004/11446 A1, 2004 ; Location in patent: Page 90 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |